Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia.
Bradstock K, Matthews J, Young G, Lowenthal R, Baxter H, Arthur C, Bashford J, Brighton T, Cannell P, Dunlop L, Durrant S, Enno A, Eliadis P, Gill D, Gillett A, Gottlieb D, Januszewicz H, Joshua D, Leahy M, Schwarer A, Taylor K; Australian Leukaemia Study Group.
Bradstock K, et al. Among authors: matthews j.
Leukemia. 2001 Sep;15(9):1331-8. doi: 10.1038/sj.leu.2402218.
Leukemia. 2001.
PMID: 11516093
Clinical Trial.